Global Regenerative Medicines Market By Overview
Introduction:
Regenerative medicines are used to heal, replace, and regenerate tissues and organs affected by the disease, injury, or natural ageing process. Regenerative medicine is the process where the body uses its systems, sometimes with the help of foreign biological material to repairs or replace tissue or organ function. It has the potential to solve the current problem of organ shortage accessible through donation, as there exists a huge patient pool who are still waiting for organ donation. Regenerative medicine makes use of stem cells and is established in a laboratory which is then safely implanted into the body when the body cannot heal itself. Moreover, it enhances the quality of life of an individual. The Global Regenerative Medicine Market accounted for US$ 7.5 billion in 2020 and is estimated to be US$ 31.44 billion by 2030 and is anticipated to register a CAGR of 15.4%.
Global Regenerative Medicines Market By Dynamics
Rising number of collaborations
The rising number of collaborations by key market players with government funding and research institutes is projected to drive the growth of the global regenerative medicines market over the forecast period. According to data published by Alliance for Regenerative Medicine (ARM), the global financing in 2016 for the regenerative medicine was estimated at US$ 5.22 billion. Out of this, US$ 2.97 billion was for cell therapy segment.
Increasing awareness about benefits of stem cell therapies
Also, increasing awareness about the benefits of stem cell therapies is anticipated to boost the growth of the target market over the forecast period. Moreover, the growing number of cases for genetic and chronic diseases and regenerative medicine providing an alternative solution for convention methods is propelling the growth of the target market. However, stringent government regulation and high investment required for developing the medicine are major factors hampering the growth of the global regenerative medicines market. Nevertheless, the developing nations are focused on technological advancements which in turn creates lucrative growth opportunities for the target market.
Global Regenerative Medicines Market By Segmentation
The global regenerative medicines market is segmented based on therapy, product type, application, and region.
Based on therapy, the global regenerative medicines market is segmented into cell therapy, tissue engineering, immunotherapy, and gene therapy. The cell therapy segment is dominating the target market and is expected to maintain its dominance over the forecast period. This is attributed due to its efficiency to restore the lost function of tissues and organs. Based on product type, the target market is segmented into cell-based products and acellular products. The cell-based products are further bifurcated into allogeneic products and autologous products.
Regional Insights:
For detailed understanding of market dynamics, based on the region the global regenerative medicines market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America dominates the global regenerative medicine market in terms of revenue contribution as related to that of markets in other regions. This is attributed to the increasing government funds for the development of regenerative medicines and the presence of dominant players in the market in this region. Europe estimates for second-highest revenue share contribution to the global regenerative medicine, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. The market in the Asia Pacific is anticipated to witness comparatively faster growth in terms of revenue over the forecast period due to the growing prevalence of chronic diseases. Besides, the global market players are spending in developing economies such as India and China.
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2030 |
|
Market Segmentation |
By Therapy- Cell Therapy, Tissue Engineering, Immunotherapy, And Gene Therapy By Product Type- cell-based products and acellular products By Application- Orthopedic & Musculoskeletal Disorders, Dermatology, Cardiology, Dermatology, Diabetes, Central Nervous System Disorders, and Others |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Detailed Segmentation:
Global Regenerative Medicines Market, By Therapy:
- Cell Therapy
- Tissue Engineering
- Immunotherapy
- Gene Therapy
Global Regenerative Medicines Market, By Product Type:
- Cell-Based Products
- Allogeneic Products
- Autologous Products
- Acellular Products
Global Regenerative Medicines Market, By Application:
- Orthopedic & Musculoskeletal Disorders
- Dermatology
- Cardiology
- Dermatology
- Diabetes
- Central Nervous System Disorders
- Others
Global Regenerative Medicines Market, By Region:
-
-
- North America
- North America Regenerative Medicines Market, By Therapy
- North America Regenerative Medicines Market, By Product Type
- North America Regenerative Medicines Market, By Application
- North America Regenerative Medicines Market, By Country
- The U.S.
- Canada
- Europe
- Europe Regenerative Medicines Market, By Therapy
- Europe Regenerative Medicines Market, By Product Type
- Europe Regenerative Medicines Market, By Application
- Europe Regenerative Medicines Market, By Country
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Asia Pacific Regenerative Medicines Market, By Therapy
- Asia Pacific Regenerative Medicines Market, By Product Type
- Asia Pacific Regenerative Medicines Market, By Application
- Asia Pacific Regenerative Medicines Market, By Country
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Latin America Regenerative Medicines Market, By Therapy
- Latin America Regenerative Medicines Market, By Product Type
- Latin America Regenerative Medicines Market, By Application
- Latin America Regenerative Medicines Market, By Country
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Middle East & Africa Regenerative Medicines Market, By Therapy
- Middle East & Africa Regenerative Medicines Market, By Product Type
- Middle East & Africa Regenerative Medicines Market, By Application
- Middle East & Africa Regenerative Medicines Market, By Country
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- North America
-
Global Regenerative Medicines Market By Key Players
The key players operating the global regenerative medicines market involves Organogenesis, Inc., Osiris Therapeutics, Inc., Pfizer Inc., Novartis AG, Vericel Corporation, NuVasive, Inc., Cook Biotech, Inc., GlaxoSmithKline plc., Boehringer Ingelheim GmbH, and Amgen, Inc. Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the products to gain a competitive edge in the target market.
Global Regenerative Medicines Market By Company Profile
-
-
- Organogenesis, Inc.
- Company Overview
- Therapy Portfolio
- Key Highlights
- Financial Performance
- Organogenesis, Inc.
-
- Osiris Therapeutics, Inc.
-
-
- Company Overview
- Therapy Portfolio
- Key Highlights
- Financial Performance
-
-
- Pfizer, Inc.
-
-
- Company Overview
- Therapy Portfolio
- Key Highlights
- Financial Performance
-
-
- Novartis AG
-
-
- Company Overview
- Therapy Portfolio
- Key Highlights
- Financial Performance
-
-
- Vericel Corporation
-
-
- Company Overview
- Therapy Portfolio
- Key Highlights
- Financial Performance
-
-
- NuVasive, Inc.
-
-
- Company Overview
- Therapy Portfolio
- Key Highlights
- Financial Performance
-
-
- Cook Biotech, Inc.
-
-
- Company Overview
- Therapy Portfolio
- Key Highlights
- Financial Performance
-
-
- GlaxoSmithKline plc.
-
-
- Company Overview
- Therapy Portfolio
- Key Highlights
- Financial Performance
-
-
- Boehringer Ingelheim GmbH
-
-
- Company Overview
- Therapy Portfolio
- Key Highlights
- Financial Performance
-
-
- Amgen, Inc.
-
-
- Company Overview
- Therapy Portfolio
- Key Highlights
- Financial Performance
-
-
Global Regenerative Medicines Market By Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Industry Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Regenerative Medicines Strategies
- Key Questions this Study will Answer
- Market Snippet, By Therapy
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Regenerative Medicines Market, By Therapy, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Cell Therapy
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Tissue Engineering
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Immunotherapy
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Gene Therapy
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Regenerative Medicines Market, By Product Type, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Cell-based Products
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Allogeneic Products
- Autologous Products
- Acellular Products
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Regenerative Medicines Market, By Application, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Orthopedic & Musculoskeletal Disorders
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Dermatology
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Cardiology
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Dermatology
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Diabetes
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Central Nervous System Disorders
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Regenerative Medicines Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Therapy, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Therapy, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Therapy, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Therapy, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Therapy, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
-
- Organogenesis, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Osiris Therapeutics, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Novartis AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Vericel Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- NuVasive, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Cook Biotech, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- GlaxoSmithKline plc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Boehringer Ingelheim GmbH
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Amgen, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Organogenesis, Inc.
-
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The global regenerative medicines market is segmented based on therapy, product type, application, and region.
The rising number of collaborations by key market players with government funding and research institutes is projected to drive the growth of the global regenerative medicines market over the forecast period.
North America dominates the global regenerative medicine market in terms of revenue contribution as related to that of markets in other regions. This is attributed to the increasing government funds for the development of regenerative medicines and the presence of dominant players in the market in this region.
The key players operating the global regenerative medicines market involves Organogenesis, Inc., Osiris Therapeutics, Inc., Pfizer Inc., Novartis AG, Vericel Corporation.